Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase IA/IB Trial of Leflunomide in Patients With PTEN-Altered Advanced Solid Malignancies and HER2 Negative Breast Cancer

NCT04997993 is registered in ClinicalTrials.gov with Deborah Doroshow as lead sponsor.

NCT NCT04997993
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04997993 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase IA/IB Trial of Leflunomide in Patients With PTEN-Altered Advanced Solid Malignancies and HER2 Negative Breast Cancer
Lead sponsor
Deborah Doroshow
Phase
Phase 1
Overall status
Recruiting
Start date
December 13, 2023
Completion date
July 31, 2028
Enrollment
23 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

pten-altered advanced solid tumors and her2 negative breast cancer